|
SASS6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.38399999927952E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43279999997858E-06 |
| Normal-vs-Stage2 |
6.46619999988829E-07 |
| Normal-vs-Stage3 |
1.71320002628761E-09 |
| Normal-vs-Stage4 |
4.3457999976404E-08 |
| Stage1-vs-Stage2 |
2.087000E-01 |
| Stage1-vs-Stage3 |
4.394500E-02 |
| Stage1-vs-Stage4 |
1.535760E-02 |
| Stage2-vs-Stage3 |
8.156800E-01 |
| Stage2-vs-Stage4 |
3.725400E-01 |
| Stage3-vs-Stage4 |
4.360000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.58549999982472E-08 |
| Normal-vs-AfricanAmerican |
7.60149999999848E-05 |
| Normal-vs-Asian |
3.395900E-04 |
| Caucasian-vs-AfricanAmerican |
4.378800E-01 |
| Caucasian-vs-Asian |
1.750550E-01 |
| AfricanAmerican-vs-Asian |
1.406980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08549999491936E-08 |
| Normal-vs-Female |
9.79209999751873E-08 |
| Male-vs-Female |
8.861600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21379999998383E-06 |
| Normal-vs-Age(41-60Yrs) |
1.35359999875462E-08 |
| Normal-vs-Age(61-80Yrs) |
1.11259999990843E-07 |
| Normal-vs-Age(81-100Yrs) |
1.042350E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.046300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.269200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.487800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.466000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.369600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.786400E-01 |
| Classical-VS-Follicular |
4.947000E-01 |
| Classical-VS-Other |
6.121600E-01 |
| Classical-VS-Normal |
9.50849999958869E-07 |
| Tall-VS-Follicular |
5.763800E-01 |
| Tall-VS-Other |
3.537800E-01 |
| Tall-VS-Normal |
2.49289999999514E-05 |
| Follicular-VS-Other |
4.968000E-01 |
| Follicular-VS-Normal |
9.75710000017393E-07 |
| Other-VS-Normal |
1.045210E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.31310000042839E-07 |
| Normal-vs-N1 |
1.79336999999169E-05 |
| N0-vs-N1 |
9.753800E-01 |
|
|
